Technetium-99m antibodies labeled with MAG3 and SHNH: An in vitro and animal in vivo comparison

Nuclear Medicine and Biology

Volumn 23, Issue 7, 1996, Pages 917-922

  Lei, K ^a   Rusckowski, M ^a   Chang, F ^a   Qu, T ^a   Mardirossian, G ^a   Hnatowich, D J ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

Antibody labeling; MAG3; SHNH

Indexed keywords

IMMUNOGLOBULIN G ANTIBODY; MERTIATIDE TC 99M; MONOCLONAL ANTIBODY TC 99M; TECHNETIUM 99M;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; ISOTOPE LABELING; MOUSE; PHARMACOKINETICS;

ANIMALS; CROSS-LINKING REAGENTS; CYSTEINE; DRUG STABILITY; IMMUNOGLOBULIN G; MALE; MICE; MICE, INBRED STRAINS; NIACINAMIDE; SUCCINIMIDES; TECHNETIUM; TECHNETIUM TC 99M MERTIATIDE; TISSUE DISTRIBUTION;

EID: 0030272779     PISSN: 09698051     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0969-8051(96)00131-X     Document Type: Article

References (14)

1. 99m-human polyclonal IgG radiolabeled via the hydrazino nicotinamide derivative for imaging focal sites of infection in rats. J. Nucl. Med. 31, 2022-2028.
2. 99mTc-hydrazino niotinic acid derivatized chemotactic peptides. Nucl. Med. Biol. 32, 25-30.
3. 99mTc-Labeled hydrazino nicotinamide derivatized cheotactic peptides for imaging focal sites of bacterial infection. J. Nucl. Med. 34, 1964-1974.
4. 4. Excel (Windows 3.1) Version 5.0.
5. 5. Fritzberg A. R., Berninger R. W., Hadley S. W. et al. (1988) Approaches to radiolabeling of antibodies for diagnosis and therapy of cancer. Pharm. Res. 5, 325-334.
6. 3 as a hippuran replacement. J. Nucl. Med. 27, 111-116.
7. 7. Hnatowich D. J., Winnard P. Jr., Virzi F., et al. (1994) Labeling deoxyribonucleic acid oligonucleotides with 99mTc. J. Nucl. Med. 36, 2306-2314.
8. 8. Hnatowich D. J., Virzi F., Fogarasi M., Winnard P. Jr. and Rusckowski M. (1994) Can a cysteine challenge assay predict the in vivo behavior of 99mTc-labeled antibodies? Nucl. Med. Biol. 21, 1035-1044.
9. 9. Hnatowich D. J., Mardirossian G., Rusckowski M., Fogarasi M., Virzi F. and Winnard P. Jr. (1993) Directly and indirectly technetium-99m-labeled antibodies: A comparison of in vitro and animal in vivo properties. J. Nucl. Med. 34, 109-119.
10. 99mTc labelling of hydrazine nicotinamide modified proteins. J. Label. Compd. Radiopharm. 35, 1-2.
11. 11. Mardirossian G., Rusckowski M., Chang F., et al. (in press) In vitro hybridization of technetium-99m-labeled peptide nucleic acid (PNA). J. Nucl. Med.
12. 188Re-labeling of monoclonal antibodies. Cancer 73, 769-773.
13. 99mTc-MAG3-HSA as possible blood pool agents. Nucl. Med. Comm. 16, 942-957.
14. 3-coupled oligonucleotides for technetium-99m labeling.